Blog

With nearly two decades of nonprofit management and fundraising experience, Melissa B. Coleman, Esq, Vice President of the PNI Foundation (PNIF), is an expert at building programmatic research teams in support of neurosciences.

Psilocybin and many other psychedelics are broadly prohibited under federal law. But US researchers at the PNI's Pacific Treatment & Research In Psychedelics (TRIP) program have been legally scrutinizing their use in a score of clinical trials.

At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.

Results from a clinical research study co-authored by physicians and scientists at the Pacific Neuroscience Institute ® (PNI) at Providence Saint John’s Health Center indicate a correlation between two modifiable risk factors – muscular strength and mobility – and brain atrophy among persons with Alzheimer’s disease.

After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).

Strange though it may seem, we can tone our brain tissue the same way we tone our muscles. The fitness of our gray matter depends on how well we take care of ourselves.

Pacific Brain Health's Director of Geriatric Cognitive Health, Scott Kaiser, MD, discusses the foods that may prevent dementia and cognitive decline.

Clinical trials using stem cells have shown promising early results as cellular therapies in regenerative medicine, as well as in potential anti-cancer applications. Read more about Dr. Achal Singh Achrol's neurosurgery clinical trials program and this leading-edge technology.

Pacific Neuroscience Institute teams in Neurology and Neurosurgery contribute to High Performing Hospitals in US News & World Report rankings.

A donor-funded program at PNI's Pacific Brain Health Center in Santa Monica offers robotic pet therapy for dementia patients.